Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF) (CAAN-AF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01522898
Recruitment Status : Recruiting
First Posted : February 1, 2012
Last Update Posted : December 11, 2017
St. Jude Medical
Boston Scientific Corporation
Information provided by (Responsible Party):
Prashanthan Sanders, University of Adelaide

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2022
  Estimated Study Completion Date : January 2022